A groundbreaking study at USC in 2021 tested MOTS-c injections in mice of various ages, from young to old
Scientific References Grasset E et al., Cell Metabolism, 2017 Cani PD et al., Nature Reviews Endocrinology, 2019 Depommier C et al., Nature Medicine, 2019 Written by Ali Rza Akn Microbiome Scientist, Author & Founder of Next-Microbiome Ali Rza Akn is a microbiome scientist with nearly 30 years of experience in translational biotechnology, systems biology, and applied microbiome research, spanning discovery, preclinical development, and clinical-stage translation
10.1053/j.semperi.2018.05.007 47 JiL.JiangP.LuB.ShengY.WangX.WangZ
Sung JJ, Kim HJ, et al
A randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder